Skip Navigation
  • The MHH
  • International office
  • Emergency numbers
  • Patients & Visitors
  • Facilities & Departments
    • Facilities & Departments
    • MHH Clinical departments
    • MHH-Institutes
    • Clinical departments and institutes sorted by center
    • Interdisciplinary centers
    • Central facilities
  • Research
    • Research
    • Research foci
      • Research foci
      • COVID-19
    • Core Research Units
      • Core Research Units
      • MeDIC
      • Hannover Unified Biobank (HUB)
      • Lasermikroskopie
      • Research Core Unit Electron Microscopy
    • Academic Career Development
    • Advisory Services
      • Advisory Services
      • DFG
    • Research Infrastructure
    • Dean of Research
    • Good Scientific Practice
      • Good Scientific Practice
      • Commission for Good Scientific Practice
      • Ombuds Office and Ombudsperson
    • Transparency in Research
    • Research Funding, Knowledge & Technology Transfer
      • Research Funding, Knowledge & Technology Transfer
      • Partners & Networks
      • For life scientists
      • For partners & investors
      • For startups and founders
  • Studying at MHH
    • Studying at MHH
    • All degree programs
    • Registrar's Office
      • Registrar's Office
      • Prospective students
      • Students
      • Dates & deadlines
      • Contact
  • Careers
Welcome to the MHH
Searched for contact. Found 531 results in 3 Millisekunden.

Filter by:

  • All content
  • Common content
  • Ambulances
  • News
  • «
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • »
News

Infectious agent offers protection against liver cancer

Relevance: 62%
 

liver diseases (research award for Dr Tetyana Yevsa). SERVICE: For further information , please contact Dr. rer. nat. Tetyana Yevsa, Yevsa.Tetyana@mh-hannover.de , phone (0511) 532-83164. The original

News

Detect liver diseases early instead of treating them late

Relevance: 62%
 

other things, research in the field of liver diseases. SERVICE: For further information , please contact Professor Dr. Michael P. Manns, manns.michael@mh-hannover.de , telephone (0511) 532-6001. The original

News

Great honour for one of the youngest MHH doctors

Relevance: 62%
 

research-based medicine. Simply create better structures!" SERVICE: For further information, please contact Dr Laura Hinze, hinze.laura@mh-hannover.de , phone (0511) 532-7880. A video in which MHH President

News

Better images for science

Relevance: 62%
 

individually according to the respective clinical picture." SERVICE: For further information, please contact Professor Dr. Tobias Ross, ross.tobias@mh-hannover.de , telephone (0511) 532-5895 or Dr. Jens Bankstahl

News

New values for better diagnoses

Relevance: 62%
 

g and was funded by the RESIST Cluster of Excellence. SERVICE: For further information , please contact Dr Christian Schultze-Florey, schultze-florey.christian@mh-hannover.de , telephone (0511) 532-2324

News

Cancer in children with Fanconi anaemia and ataxia telangiectatica

Relevance: 62%
 

(DFG), the Gerdes Foundation and the Schroeder-Kurth Fund. SERVICE: For further information , please contact Professor Dr. Christian Kratz, Department of Paediatric Haematology and Oncology, Hanover Medical

News

Gold standard for multiple sclerosis care

Relevance: 62%
 

make reliable prognoses on the development of the disease. SERVICE: For further information, please contact Professor Dr. Dr. Mike P. Wattjes, wattjes.mike@mh-hannover.de, telephone (0511) 532-2061. You can

News

Every single cell counts - even before birth!

Relevance: 62%
 

restricted TCR diversity persists into adulthood" can be found here . For more information , please contact Professor Dr Sarina Ravens, Ravens.Sarina@mh-hannover.de and Professor Dr Immo Prinz, Prinz.Immo

Page

Main treatment areas and tests

Relevance: 62%
 

SensWear wristband) Newborn screening Newborn screening: sweat test diagnostics For appointments please contact the colleagues at +49 511 532 3251 or +49 1761 532 8601. The following consultations take place regularly

Page

Research Core Unit Transcriptomics

Relevance: 62%
 

carefully planned experimental study design. Therefore, the planning stage is the ideal time to get in contact with us. Manuals Introduction to experimental Microarray designs PDF Introduction to standard Excel

  • «
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • »
Imprint Intranet Contact Privacy Accessibility
The MHH Hospital is a maximum care hospital with a nationwide catchment area. The university teaches medicine, dentistry, biochemistry, biomedicine, midwifery and health sciences. The main research areas are Transplantation and Stem Cell Research / Regenerative Medicine, Infection and Immunology Research, Biomedical Engineering and Implant Research.

   

Information about

Blood donation service MHH-Alumni e.V.

Follow us on

Facebook Instagram YouTube Xing LinkedIn
© 2019 - 2025 Medizinische Hochschule Hannover
Nach oben scrollen